ATRS Key Stats
|Revenue (Quarterly YoY Growth)||-3.13%|
|EPS Diluted (TTM)||-0.1606|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-19.88M|
|Gross Profit Margin (Quarterly)||45.45%|
|Profit Margin (Quarterly)||-115.5%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
- Antares' CEO Presents at Oppenheimer 24th Annual Healthcare Conference (Transcript) Dec 11
- 4 December 2013 Antares to Present at the Oppenheimer 24th Annual Healthcare Conference noodls Dec 5
- Antares Pharma to Present at the Oppenheimer 24th Annual Healthcare Conference Business Wire Dec 4
- 3 Disruptive Medical Innovations You Can Invest In Fool Dec 3
- 26 November 2013 Antares Pharma Announces Additional US Patent Protection for Otrexup noodls Dec 2
- Antares Pharma Announces Additional U.S. Patent Protection for OTREXUP™ Business Wire Nov 26
- Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development Business Wire Nov 19
- 15 November 2013 Antares Pharma To Present At The Jefferies 2013 Global Healthcare Conference noodls Nov 15
- Antares Pharma to Present at the Jefferies 2013 Global Healthcare Conference Nov 15
- Antares Marketing Agreement With Leo On Otrexup Is A Nice Positive Seeking Alpha Nov 14
ATRS Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Antares Pharma is up 3.13% over the last year vs S&P 500 Total Return up 27.18%, Biolase down 4.82%, and AngioDynamics up 47.33%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for ATRS
Pro Report PDF for ATRS
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download ATRS Pro Report PDF
Pro Strategies Featuring ATRS
Did Antares Pharma make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Antares Pharma, Inc., is a specialty pharmaceutical company developing and commercializing self-administered parenteral pharmaceutical products and technologies and topical gel-based products. Its products include OTREXUP™ and Medi-Jet™.